SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-17-012654
Filing Date
2017-11-09
Accepted
2017-11-09 12:04:27
Documents
39
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 229135
2 ex10-1.htm EX-10.1 1028
3 ex10-2.htm EX-10.2 1320
4 ex31-1.htm EX-31.1 15589
5 ex31-2.htm EX-31.2 15863
6 ex32-1.htm EX-32.1 7264
7 img_001.jpg GRAPHIC 8213
8 ex10-1_001.jpg GRAPHIC 310163
9 ex10-2_001.jpg GRAPHIC 1123153
  Complete submission text file 0001493152-17-012654.txt   2924456

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE FILE vapa-20170930.xml EX-101.INS 61176
11 XBRL SCHEMA FILE vapa-20170930.xsd EX-101.SCH 12161
12 XBRL CALCULATION FILE vapa-20170930_cal.xml EX-101.CAL 22392
13 XBRL DEFINITION FILE vapa-20170930_def.xml EX-101.DEF 29548
14 XBRL LABEL FILE vapa-20170930_lab.xml EX-101.LAB 91568
15 XBRL PRESENTATION FILE vapa-20170930_pre.xml EX-101.PRE 73555
Mailing Address 5550 NICOLLET AVENUE MINNEAPOLIS MN 55419
Business Address 5550 NICOLLET AVENUE MINNEAPOLIS MN 55419 612-812-2037
VapAria Corp (Filer) CIK: 0001479915 (see all company filings)

IRS No.: 271521364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55470 | Film No.: 171189671
SIC: 2834 Pharmaceutical Preparations